Jim Simons Compass Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 140,600 shares of CMPX stock, worth $254,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140,600
Previous 70,400
99.72%
Holding current value
$254,486
Previous $139,000
0.72%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CMPX
# of Institutions
82Shares Held
92.8MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$40.5 Million0.54% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$20.1 Million0.02% of portfolio
-
Blackstone Inc New York, NY7.69MShares$13.9 Million0.03% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$12 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.51MShares$9.98 Million0.17% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $183M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...